• University of Cambridge Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • London School of Economics and Political Science Featured PhD Programmes
  • University of Mannheim Featured PhD Programmes
  • Carlos III Health Institute Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
University of Liverpool Featured PhD Programmes
Manchester Metropolitan University Featured PhD Programmes
University of Oxford Featured PhD Programmes
Newcastle University Featured PhD Programmes
University of Manchester Featured PhD Programmes

Development of novel Silanediol HDAC inhibitors for cancer treatment

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr Jonathan Sellars
    Dr Jason Gill
  • Application Deadline
    No more applications being accepted
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

PLEASE NOTE THAT THIS PROJECT IS FOR SELF-FUNDED STUDENTS.

Applications are invited from Graduates in Chemistry, Pharmacy and Medicinal Chemistry Master’s level programs to join our group within the School of Medicine, Pharmacy and Health. The project encompasses the synthesis and biological screening of a novel group of new protease inhibitors for the treatment of cancers.

Histone Deacetylase enzymes are zinc dependent metalloproteases which are involved in chromatin remodeling and gene expression by acetyl cleavage from histone lysine residues. It is a promising target for inhibitors as hyper-acetylation leads to cell-cycle arrest and apoptosis in tumor cells. Therefore, our project will involve the following a. combinatorial synthesis of a library of diverse structural silanediol analogues; b. iterative testing of the compound library will be undertaken in-house and international biology partners to elucidate the biological activity and aid the design of more potent analogues. You will undertake the synthesis and in-house testing of these compounds in our world leading facilities here at Durham, where you will have access to state of the art laboratories and analytical equipment.

Potential candidates will require a strong background in chemical synthesis, with background knowledge of microbiological techniques and protein purification being advantageous.

Successful candidates will be encouraged to participate in national and international conferences on cancer.

Funding Notes

PLEASE NOTE THAT THE PROJECT IS FOR SELF-FUNDED STUDENTS.

For project enquiries please contact the lead supervisor. For other enquiries please contact the Research Student Administrator.

References

Please check that you meet our entry requirements. See our website https://www.dur.ac.uk/school.health/research/degrees/entry/ for further information.

Share this page:

Cookie Policy    X